“…In the present study, after the administration of Sig-1R agonist PRE-084, the anxiety-like behaviors and cognitive impairments were significantly reversed, indicating therapeutic benefits of activating the Sig-1R pathway. A large number of studies have shown that Sig-1R activation yields a neuroprotective effect in a variety of diseases, such as ischemia/reperfusion, Alzheimer's disease, and pain [12,13,35,36]. However, Yin et al reported that Sig-1R deficiency reduced ß-amyloid-induced hippocampal neuronal cell death and cognitive deficits, contrary to the mainstream results [37].…”